glp-1 drugs for parkinson's disease Are we measuring the wrong primary outcome for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep glp-1 drugs and parkinson's disease
Pay in 4 interest-free payments of $6.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15



:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)











.png)









![Exploration [Urza's Saga] 2019 Gold Sarcophagus Tin](https://cdn.shopify.com/s/files/1/0617/9821/9946/products/b9b540fb-71d3-554d-a676-7e9c381050e6.jpg?v=1658565621)


